The use of GnRH agonists in precocious puberty

European Journal of Endocrinology

Volumn 159, Issue SUPPL. 1, 2008, Pages

  Mul, D ^a   Hughes, I A ^b   Van Mil, E G A H ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Department of Paediatrics   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; DECAPEPTYL SR; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GOSERELIN; LEUPRORELIN; LUTEINIZING HORMONE; TESTOSTERONE; TRIPTORELIN; UNCLASSIFIED DRUG; GONADORELIN;

AGE DETERMINATION; ANTHROPOMETRY; BODY HEIGHT; BODY MASS; BONE AGE; BONE DENSITY; BREAST DEVELOPMENT; CENTRAL PRECOCIOUS PUBERTY; CLINICAL ASSESSMENT; CONFERENCE PAPER; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG RELEASE; DRUG SYNTHESIS; ECHOGRAPHY; HEADACHE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PEDIATRICS; PHYSICAL EXAMINATION; PRECOCIOUS PUBERTY; REPRODUCTION; SEX DETERMINATION; SYMPTOMATOLOGY; THERAPY EFFECT; TREATMENT DURATION; TREATMENT INDICATION; VISUAL DISORDER; BREAST; CHILD; CHILD DEVELOPMENT; DRUG EFFECT; DRUG POTENTIATION; FEMALE; GROWTH; GROWTH, DEVELOPMENT AND AGING; NOMENCLATURE; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; REVIEW; SOCIAL CHANGE; TREATMENT OUTCOME;

BODY HEIGHT; BREAST; CHILD; CHILD DEVELOPMENT; FEMALE; GONADOTROPIN-RELEASING HORMONE; GROWTH; HUMANS; PSYCHOLOGY; PUBERTY, PRECOCIOUS; SOCIAL CHANGE; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME;

EID: 58749102795     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0814     Document Type: Conference Paper

References (39)

1. Huirne JA, Lambalk CB, van Loenen AC, Schats R, Hompes PG, Fauser BC & Macklon NS. Contemporary pharmacological manipulation in assisted reproduction. Drugs 2004 64 297-322.
2. Buck Louis GM, Gray LE Jr, Marcus M, Ojeda SR, Pescovitz OH, Witchel SF, Sippell W, Abbott DH, Soto A, Tyl RW, Bourguignon JP, Skakkebaek NE, Swan SH, Golub MS, Wabitsch M, Toppari J & Euling SY. Environmental factors and puberty timing: expert panel research needs. Pediatrics 2008 3 (Suppl 3) S192-S207.
3. Gluckman PD & Hanson MA. Evolution, development and timing of puberty. Trends in Endocrinology and Metabolism 2006 17 7-12.
4. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MBL, Crowley WF Jr, Aparicio SAJR & Colledge WH. The GPR54 gene as a regulator of puberty. New England Journal of Medicine 2003 349 1614-1627.
5. Silveria LFG, Santos MAG & Brito VN. Two KISS1 mutations associated with gonadotrophin-dependent precocious puberty. (abstract FC2-76) Hormone Research 2008 70 (Suppl 2) 20.
6. Roa J, Aguilar E, Dieguez C, Pinilla L & Tena-Sempere M. New frontiers in kisspeptin/GPR54 physiology as fundamental gatekeepers of reproductive function. Frontiers in Neuroendocrinology 2008 29 48-69.
7. Lahlou N, Carel J, Chaussain J & Roger M. Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics. Journal of Pediatric Endocrinology and Metabolism 2000 13 (Suppl 1) 723-737.
8. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG & Hasemeier CM. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings Network. Pediatrics 1997 99 505-512.
9. Mul D, Oostdijk W & Drop SL. Early puberty in adopted children. Hormone Research 2002 57 1-9.
10. Teilmann G, Pedersen CB, Skakkebaek NE & Jensen TK. Increased risk of precocious puberty in internationally adopted children in Denmark. Pediatrics 2006 118 e391-e399.
11. Teilmann G, Parent A-S, Skakkebaek NE & Bourguignon JP. Precocious puberty in adopted girls. In When Puberty is Precocious. Scientific and Clinical Aspects, pp 443-459. Eds OH Pescovitz & E Walvoord, Totowa, New Jersey: Humana Press Inc, 2007.
12. Prete G, Couto-Silva AC, Trivin C & Brauner R. Idiopathic central precocious puberty in girls: presentation factors. BMC Pediatrics 2008 8 27.
13. Carel JC & Leger J. Clinical practice. Precocious puberty. New England Journal of Medicine 2008 358 2366-2377.
14. Pescovitz OH, Hench KD, Barnes KM, Loriaux DL & Cutler GB Jr. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone. Journal of Clinical Endocrinology and Metabolism 1988 67 474-479.
15. Pasquino AM, Pucarelli I, Passeri F, Segni M, Mancini MA & Municchi G. Progression of premature thelarche to central precocious puberty. Journal of Pediatrics 1995 126 11-14.
16. Wit JM, Ranke M & Kelnar CJH Eds. ESPE Classification of Paediatric Endocrine Diagnoses. Karger. Basel: Karger, 2007.
17. Resende EAMR, Lara BHJ, Reis JD, Ferreira BP, Pereira GA & Borges MF. Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by immunochemiluminometric and immunofluorometric assays in normal children. Journal of Clinical Endocrinology and Metabolism 2007 92 1424-1429.
18. Chalumean M, Hadjiathanasiou CG, Ng SM, Cassio A, Mul D, Cisternino M, Partsch CJ, Theodoridis C, Didi M, Cacciari E, Oostdijk W, Borghesi A, Sippell WG, Bréart G & Brauner R. Selecting girls with precocious puberty for brain imaging: validation of European evidence-based diagnosis rule. Journal of Pediatrics 2003 143 445-450.
19. Sigurjonsdottir TJ & Hayles AB. Precocious puberty. A report of 96 cases. American Journal of Diseases of Children 1968 115 309-321.
20. Carel JC, Lahlou N, Roger M & Chaussain JL. Precocious puberty and statural growth. Human Reproduction Update 2004 10 135-147.
21. Johansson T & Ritzen EM. Very long-term follow-up of girls with early and late menarche. Endocrine Development 2005 8 126-136.
22. Tremblay L & Frigon JY. Precocious puberty in adolescent girls: a biomarker of later psychosocial adjustment problems. Child Psychiatry and Human Development 2005 36 73-94.
23. Worley G, Houlihan CM & Herman-Giddens ME. Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey. Pediatrics 2002 110 897-902.
24. Albanese A & Hopper NW. Suppression of menstruation in adolescents with severe learning difficulties. Archives of Disease in Childhood 2007 92 629-632.
25. Cohen-Kettenis PT, Delemarre-van de Waal HA & Gooren LJ. The treatment of adolescent transsexuals: changing insights. Journal of Sexual Medicine 2008 5 1892-1897.
26. Giordano S. Lives in a chiaroscuro. Should we suspend the puberty of children with gender identity disorder? Journal of Medical Ethics 2008 34 580-584.
27. Eugster EA, Clarke W, Kletter GB, Lee PA, Neely EK, Reiter EO, Saenger P, Shulman D, Silverman L, Flood L, Gray W & Tierney D. Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial. Journal of Clinical Endocrinology and Metabolism 2007 92 1697-1704.
28. Carel JC, Blumberg J, Seymour C, Adamsbaum C & Lahlou N for the Triptorelin 3-month CPP Study Group. Three-month sustained-release Triptorelin (11.25 mg) in the treatment of central precocious puberty. European Journal of Endocrinology 2006 154 119-124.
29. Bertelloni S & Mul D. Treatment of central precocious puberty by GnRH analogs: long-term outcome in men. Asian Journal of Andrology 2008 10 525-534.
30. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A & Laron Z. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Hormone Research 1997 47 54-61.
31. Pasquino AM, Pucarelli I, Accardo F, Demiraj V, Segni M & Di Nardo R. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function. Journal of Clinical Endocrinology and Metabolism 2008 93 190-195.
32. Brito VN, LatronicoAC, Cukier P, Teles MG, Silveira LFG, Arnhold IJP & Mendonca BB. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs. Journal of Clinical Endocrinology and Metabolism 2008 93 2662-2669.
33. Weise M, Flor A, Barnes KM, Cutler GB Jr & Baron J. Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty. Journal of Clinical Endocrinology and Metabolism 2004 89 103-107.
34. Mul D, Oostdijk W, Waelkens JJ & Drop SL. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone. Clinical Endocrinology 2005 63 185-190.
35. Heger S, Muller M, Ranke M, Schwarz HP, Waldhauser F, Partsch CJ & Sippell WG. Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function. Molecular and Cellular Endocrinology 2006 254-255 217-220.
36. van der Sluis IM, Boot AM, Krenning EP, Drop SLS & de Muinck Keizer-Schrama S. Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy. Journal of Clinical Endocrinology and Metabolism 2002 87 506-512.
37. Partsch JC, Heger S & Sippell WG. Management and outcome of central precocious puberty. Clinical Endocrinology 2002 56 129-148.
38. Hughes IA & Kumanan M. A wider perspective on puberty. Molecular and Cellular Endocrinology 2006 254-255 1-7.
39. Mrug S, Elliott M, Gilliland MJ, Grunbaum JA, Tortolero SR, Cuccaro P & Schuster M. Positive parenting and early puberty in girls: protective effects against aggressive behaviour. Archives of Pediatrics & Adolescent Medicine 2008 162 781-786.